hospit
accept
confirm
case
coronaviru
diseas
sinc
februari
design
type
infecti
diseas
medic
institut
infecti
diseas
ward
provid
inpati
care
independ
neg
pressur
ventil
environ
separ
gener
practic
ward
patient
hospit
februari
patient
physic
symptom
radiolog
find
pneumonia
possibl
efficaci
ciclesonid
trade
name
alvesco
discuss
emerg
expans
meet
new
coronaviru
infect
held
februari
ciclesonid
inhal
start
februari
patient
poor
oxygen
ct
find
hospit
three
case
clinic
cours
reveal
favor
regard
report
consent
patient
obtain
case
femal
year
old
embark
diamond
princess
januari
land
hong
kong
januari
sore
throat
malais
loss
appetit
note
februari
fever
appear
februari
specimen
wa
submit
februari
result
throat
swab
pcr
test
februari
posit
februari
disembark
transport
hospit
statu
first
consult
gc
blood
pressur
mmhg
puls
rate
respiratori
rate
bodi
temperatur
spo
ra
physic
find
pharyng
red
lymphadenopathi
breath
sound
fine
crackl
heard
end
inspir
lower
posterior
lung
field
past
histori
collagen
diseas
diagnos
treatment
given
followup
ongo
due
antinuclear
antibodi
discret
type
blood
collect
admiss
poor
color
tone
finger
suspect
scleroderma
laboratori
find
list
tabl
chest
xray
admiss
feb
reveal
infiltr
shadow
lower
right
lung
field
fig
chest
ct
day
demonstr
ggo
along
pleura
middl
lower
lung
field
fig
clinic
cours
illustr
fig
admiss
start
nasal
maintain
spo
felt
fatigu
lie
almost
time
could
hardli
take
food
poor
commun
disorient
interview
later
memori
time
hospit
although
mainten
infus
ctrx
azm
start
oxygen
gradual
worsen
fever
higher
poor
food
intak
contin
u
februari
requir
maintain
spo
tablet
lopinavir
ritonavir
lpvr
mg
start
start
lpvr
fever
tend
decreas
oxygen
also
improv
nasal
requir
maintain
spo
easili
drop
around
spo
bodi
movement
appetit
improv
consider
fatigu
ct
shadow
ggo
becam
stronger
area
enlarg
fig
addit
diarrhea
elev
liver
enzym
appear
diarrhea
liver
damag
loss
appetit
consid
side
effect
lpvr
henc
lpvr
discontinu
februari
poor
food
intak
continu
one
week
nasal
tube
feed
start
ciclesonid
inhal
twice
day
start
februari
within
day
start
ciclesonid
fever
oxygen
improv
spo
could
maintain
room
air
hypoxemia
bodili
movement
also
improv
appetit
remark
recov
tube
feed
discontinu
februari
follow
voluntari
food
intak
kcal
gener
fatigu
improv
becam
abl
walk
indoor
without
aid
patient
judg
improv
nasal
swab
pcr
test
perform
twice
februari
found
neg
discharg
februari
ct
februari
pneumonia
markedli
improv
fig
current
inhal
twice
daili
continu
end
kit
outpati
followup
plan
embark
diamond
princess
januari
februari
dri
cough
fatigu
loss
appetit
diarrhea
appear
abl
eat
almost
solid
food
fever
also
note
throat
sw
ab
pcr
februari
posit
admit
hospit
februari
statu
first
consult
alert
consciou
mark
fatigu
blood
pressur
mmhg
puls
respiratori
rate
bodi
temperatur
po
ra
physic
find
pharyng
red
lymphadenopathi
abnorm
pulmonari
sound
smoke
histori
previous
smoke
cigarettesday
current
smoke
laboratori
find
list
tabl
chest
xray
found
infiltr
shadow
lower
right
lung
field
fig
chest
ct
document
ggo
observ
middl
lower
lung
field
right
left
fig
clinic
cours
illustr
fig
bodi
temperatur
admiss
increas
next
day
oxygen
al
good
time
admiss
decreas
spo
februari
nasal
start
maintain
spo
februari
requir
wateri
stool
persist
almost
unabl
eat
food
sinc
admiss
ciclesonid
twice
day
start
februari
februari
appetit
gradual
improv
diarrhea
recov
stool
becam
normal
februari
oxygen
stop
fatigu
improv
ate
almost
meal
recov
point
could
daili
squat
indoor
pharyng
swab
pcr
perform
februari
februari
result
posit
mar
result
nasal
swab
pcr
still
posit
radiolog
find
ct
scan
improv
fig
ciclesonid
increas
time
day
past
medic
histori
abnorm
xray
shadow
found
previou
medic
checkup
follow
ct
laboratori
find
list
tabl
chest
xray
feb
reveal
infiltr
shadow
hilar
portion
right
middl
lung
field
fig
chest
ct
feb
ggo
found
posterior
midlow
lung
field
side
bronchiectasi
cavit
calcif
found
right
lung
fig
cavern
lesion
care
examin
anoth
hospit
cours
diseas
follow
without
sign
deterior
admiss
expector
sputum
difficult
mycobacteria
test
perform
clinic
cours
illustr
fig
time
admiss
bodi
temperatur
oxygen
good
admit
f
atigu
often
lie
bed
ate
half
portion
meal
prevent
exacerb
ciclesonid
start
februari
fine
crackl
heard
back
chest
auscult
februari
ct
show
ggo
posterior
lower
lung
field
side
day
spo
decreas
less
bodili
movement
nasal
start
ciclesonid
twice
day
administ
alon
followup
februari
oxygen
improv
administr
oxygen
discontinu
appetit
began
improv
februari
pm
februari
abl
eat
complet
meal
gener
fatigu
improv
rapidli
pharyng
swab
pcr
perform
februari
result
posit
nasal
swab
pcr
perform
mar
neg
mar
posit
radiolog
find
ct
scan
mar
improv
ciclesonid
increas
dose
treat
case
mild
midstag
ciclesonid
inhal
steroid
obtain
favor
result
although
still
preliminari
unpublish
data
coronaviru
laboratori
nation
institut
infecti
diseas
murayama
branch
experiment
data
among
exist
inhal
drug
treatment
bronchial
asthma
ciclesonid
trade
name
alvesco
strong
antivir
activ
addit
accord
anoth
screen
studi
includ
fdaapprov
drug
ciclesonid
also
antivir
activ
mer
viru
ciclesonid
safe
drug
wide
use
steroid
inhal
prematur
babi
newborn
elderli
said
effect
control
chronic
inflamm
respiratori
tract
although
patholog
lung
injuri
yet
elucid
estim
mer
sar
viru
replic
alveolar
epitheli
cell
caus
lung
damag
simultan
infect
alveolar
macrophag
thought
caus
local
inflamm
expect
antivir
antiinflammatori
effect
ciclesonid
effect
treat
lung
injuri
caus
coronaviru
becom
sever
antivir
effect
current
found
inhal
steroid
ciclesonid
report
steroid
treatment
recommend
due
possibl
prolong
viremia
complic
diabet
although
system
administr
hydrocortison
methylprednisolon
dexamethason
prednisolon
consid
ciclesonid
inhal
prodrug
stay
lung
surfac
minor
increas
blood
level
prefer
given
pneumonia
diseas
becom
sever
expect
effect
rapidli
improv
patient
symptom
prevent
progress
sever
pneumonia
standard
dose
adult
day
maximum
dose
twice
day
base
viral
replic
time
consid
frequent
highdos
administr
necessari
reach
enough
drug
alveoli
furthermor
thought
desir
continu
day
longer
start
avoid
reactiv
residu
viru
appear
resist
viru
sinc
viru
replic
alveolar
epitheli
cell
consid
inhal
deepli
possibl
enhanc
effect
base
consider
dosag
form
propos
use
follow
dose
standard
time
immedi
admiss
symptom
pneumonia
becam
rather
seriou
note
mani
report
seem
worsen
rapidli
day
onset
even
initi
symptom
mild
time
hospit
unabl
provid
respir
infecti
diseas
ward
felt
great
danger
pneumonia
patient
worsen
symptom
start
administr
ciclesonid
immedi
receiv
inform
februari
particular
case
develop
pneumonia
time
admiss
start
lpvr
escap
acut
phase
inflamm
poor
oxygen
continu
loss
appetit
prolong
becam
physic
weak
danger
acut
exacerb
ct
show
worsen
trend
consid
transfer
anoth
hospit
due
serious
ill
patient
forc
put
standbi
tri
look
transfer
destin
receiv
inform
possibl
favor
effect
ciclesonid
start
administr
result
rapid
improv
describ
impress
case
among
former
pneumonia
patient
requir
respiratori
manag
beforehand
introduct
case
reliev
symptom
howev
diseas
background
differ
patient
efficaci
discuss
limit
number
observ
case
case
mainli
elderli
show
sever
symptom
elderli
patient
case
weak
due
pneumonia
safeti
establish
effect
confirm
earli
administr
ciclesonid
simpl
inexpens
lpvr
consid
great
merit
greatli
anticip
case
ciclesonid
use
collect
studi
futur
author
certifi
affili
involv
organ
entiti
financi
interest
honoraria
educ
grant
particip
speaker
bureau
membership
employ
consult
stock
ownership
equiti
interest
expert
testimoni
patentlicens
arrang
nonfinanci
interest
person
profession
relationship
affili
knowledg
belief
subject
matter
materi
discuss
manuscript
infiltr
shadow
shown
lower
right
lung
field
lleft
axial
left
coron
right
section
chest
xray
demonstr
featur
ggo
along
pleura
middl
lower
lung
field
shadow
ggo
becam
stronger
area
enlarg
infiltr
shadow
shown
lower
right
lung
field
infiltr
shadow
found
hilar
portion
right
middl
lung
field
ggo
found
posterior
midlow
lung
field
side
bronchiectasi
cavit
calcif
found
right
lung
